Published in Gastroenterology on March 21, 2007
The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88
Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis (2009) 2.44
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One (2012) 1.66
Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol (2011) 1.65
Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther (2011) 1.52
Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2010) 1.48
Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010. World J Gastroenterol (2011) 1.40
Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy (2011) 1.26
Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol (2014) 1.25
Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario. Gut Pathog (2009) 1.17
The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver (2010) 1.12
Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS One (2008) 1.12
Crohn's disease: an immune deficiency state. Clin Rev Allergy Immunol (2010) 1.10
Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci (2008) 1.08
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol (2009) 1.06
On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. PLoS One (2008) 1.04
Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Medicine (Baltimore) (2014) 1.03
Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states. J Infect Dis (2010) 1.02
The gut microbiota and inflammatory bowel disease. Semin Immunopathol (2014) 1.01
Medical management of Crohn's disease. BMJ (2008) 0.97
Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech (2014) 0.96
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int (2013) 0.95
Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol (2008) 0.95
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: a review of the controversy from the clinician's perspective. Can J Gastroenterol (2010) 0.94
High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J Gastroenterol (2010) 0.93
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol (2014) 0.92
Microbial manipulation as primary therapy for Crohn's disease. World J Gastroenterol (2013) 0.92
The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin Transl Gastroenterol (2015) 0.92
On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis. PLoS One (2008) 0.89
Fecal detection of Mycobacterium avium paratuberculosis using the IS900 DNA sequence in Crohn's disease and ulcerative colitis patients and healthy subjects. Dig Dis Sci (2011) 0.89
Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med (2012) 0.88
Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) (2016) 0.88
Perturbation of the human microbiome as a contributor to inflammatory bowel disease. Pathogens (2014) 0.88
A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease. J Gastroenterol (2015) 0.86
Use of antibiotics in the treatment of Crohn's disease. World J Gastroenterol (2013) 0.86
RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis. Gut Pathog (2016) 0.85
Pathogenesis of Crohn's disease: Bug or no bug. World J Gastrointest Pathophysiol (2015) 0.84
Antimycobacterial therapy in Crohn's disease: game over? Gastroenterology (2007) 0.84
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn's disease, cause or epiphenomenon? World J Gastroenterol (2014) 0.83
The Association of Mycobacterium avium subsp. paratuberculosis with Inflammatory Bowel Disease. PLoS One (2016) 0.82
Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr (2014) 0.81
Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies. BMC Syst Biol (2015) 0.81
Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease? Dig Dis Sci (2017) 0.81
Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric culture. Gut Pathog (2009) 0.80
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease. World J Gastroenterol (2008) 0.80
Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis. World J Gastroenterol (2015) 0.79
Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches. Curr Treat Options Gastroenterol (2015) 0.79
Importance of the Australian Crohn's disease antibiotic study. Gastroenterology (2007) 0.78
Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis. Front Immunol (2015) 0.77
The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study. Gastroenterology (2007) 0.77
Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol (2017) 0.77
Australian Crohn's antibiotic study opens new horizons. Gastroenterology (2007) 0.76
Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol (2016) 0.76
Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism. Gut (2016) 0.76
Flawed Australian CD study does not end MAP controversy. Gastroenterology (2007) 0.76
The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res (2017) 0.75
Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment. Case Rep Gastroenterol (2014) 0.75
Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis. Aliment Pharmacol Ther (2015) 0.75
Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: Controversy resolution requires the patient perspective, not the clinician perspective. Can J Gastroenterol (2011) 0.75
A Potential 'Curative' Modality for Crohn's Disease---Modeled after Prophylaxis of Bovine Johne's Disease. Mycobact Dis (2012) 0.75
Crohn's disease. BMJ Clin Evid (2011) 0.75
Microbiome Changes during Tuberculosis and Antituberculous Therapy. Clin Microbiol Rev (2016) 0.75
Suspected intestinal tuberculosis might be Crohn's disease. Case Rep Med (2010) 0.75
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes (2017) 0.75
Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. Gastroenterol Hepatol (N Y) (2013) 0.75
Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease. Future Sci OA (2015) 0.75
Yet Another Flawed "Placebo Controlled" Study in Crohn's Disease? Foodborne Pathog Dis (2015) 0.75
Is Mycobacterium avium paratuberculosis the Trigger in the Crohn's Disease Spectrum? Open Forum Infect Dis (2017) 0.75
The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017. Front Public Health (2017) 0.75
Anaerobic adaptation of Mycobacterium avium subspecies paratuberculosis in vitro: similarities to M. tuberculosis and differential susceptibility to antibiotics. Gut Pathog (2017) 0.75
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood (2002) 4.06
Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol (2005) 3.00
Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis (2009) 2.26
Why do medical graduates choose rural careers? Rural Remote Health (2009) 2.00
Capsule endoscopy vs. push enteroscopy and enteroclysis in suspected small-bowel Crohn's disease. Gastrointest Endosc (2005) 1.95
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology (2002) 1.94
A mouse model of hereditary folate malabsorption: deletion of the PCFT gene leads to systemic folate deficiency. Blood (2011) 1.62
Can bacterial endotoxin exposure reverse atopy and atopic disease? J Allergy Clin Immunol (2004) 1.54
Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer. Clin Nucl Med (2013) 1.50
Fetal glucocorticoid-regulated pathways are not affected by inhaled corticosteroid use for asthma during pregnancy. Am J Respir Crit Care Med (2010) 1.50
Learning opportunities for Australian prevocational hospital doctors: exposure, perceived quality and desired methods of learning. Med J Aust (2006) 1.46
Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One (2009) 1.42
Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet (2013) 1.34
Severe asthma exacerbations during pregnancy. Obstet Gynecol (2005) 1.27
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. J Crohns Colitis (2012) 1.21
Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol (2008) 1.21
Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy (2011) 1.09
Thoracic epidural anesthesia for cardiac surgery: the effects on tracheal intubation time and length of hospital stay. Anesth Analg (2002) 1.05
Telehealth practice recommendations for diabetic retinopathy. Telemed J E Health (2004) 1.04
Maternal and neonatal outcomes of pregnancies complicated by asthma in an Australian population. Aust N Z J Obstet Gynaecol (2009) 1.04
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis (2007) 1.03
The multiple mini-interview: how long is long enough? Med Educ (2009) 1.02
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. Inflamm Bowel Dis (2011) 1.01
The inflammatory infiltrate in the acute stage of the dextran sulphate sodium induced colitis: B cell response differs depending on the percentage of DSS used to induce it. BMC Clin Pathol (2001) 1.01
Randomized trial of a decision aid for patients with cystic fibrosis considering lung transplantation. Am J Respir Crit Care Med (2009) 0.99
Community mental healthcare providers' attitudes and practices related to smoking cessation interventions for people living with severe mental illness. Patient Educ Couns (2009) 0.99
Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest Ophthalmol Vis Sci (2011) 0.99
A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease. PLoS One (2013) 0.97
Impact of colonoscopy bowel preparation on intestinal microbiota. PLoS One (2013) 0.95
Microscopic colitis. J Gastroenterol Hepatol (2002) 0.94
General practitioners' referral letters--Do they meet the expectations of gastroenterologists and rheumatologists? Aust Fam Physician (2006) 0.93
Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review. J Gastroenterol Hepatol (2013) 0.93
High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis (2010) 0.93
Self-rated preparedness of Australian prevocational hospital doctors for emergencies. Emerg Med Australas (2008) 0.91
Natalizumab therapy for moderate to severe Crohn disease in adolescents. J Pediatr Gastroenterol Nutr (2007) 0.91
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J (2007) 0.90
Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol (2007) 0.89
Bone loss in Crohn's disease: exercise as a potential countermeasure. Inflamm Bowel Dis (2005) 0.87
Referring patients to specialists: a structured vignette survey of Australian and British GPs. BMC Fam Pract (2008) 0.87
Outcomes of endoscopic resection of large colorectal neoplasms: an Australian experience. J Gastroenterol Hepatol (2009) 0.87
Nutrition competencies for the prevention and treatment of disease in Australian medical courses. Med J Aust (2012) 0.86
An umbrella review: corticosteroid therapy for adults with acute asthma. Am J Med (2009) 0.86
Workshop--cough: exercise, speech and music. Pulm Pharmacol Ther (2008) 0.85
Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation. J Clin Endocrinol Metab (2011) 0.84
Psychological well-being and quality of life in Crohn's disease patients with an ostomy: a preliminary investigation. J Wound Ostomy Continence Nurs (2013) 0.83
Biomedical studies on temporal bones of the first multi-channel cochlear implant patient at the University of Melbourne. Cochlear Implants Int (2014) 0.82
Population-based screening for Lynch syndrome in Western Australia. Int J Cancer (2014) 0.81
Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: a survey of current practices. J Gastroenterol Hepatol (2011) 0.81
Sex-specific associations between cortisol and birth weight in pregnancies complicated by asthma are not due to differential glucocorticoid receptor expression. Thorax (2010) 0.81
Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol (2006) 0.80
Early toxicology signal generation in the mouse. Toxicol Pathol (2010) 0.80
Crohn's disease and smoking: is it ever too late to quit? J Crohns Colitis (2013) 0.80
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. Am Heart J (2007) 0.80
The use of cone-beam computed tomography to determine cochlear implant electrode position in human temporal bones. Otol Neurotol (2014) 0.79
P-glycoprotein expression in Helicobacter pylori-positive patients: the influence of MDR1 C3435T polymorphism. J Dig Dis (2012) 0.79
Society of gynecologic oncologists position paper: breast cancer care. Gynecol Oncol (2008) 0.79
A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.78
More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis. J Clin Pathol (2010) 0.78
Gastroesophageal Intussusception Associated with Pneumonectomy in a Dog. Contemp Top Lab Anim Sci (1997) 0.78
Update in inflammatory bowel disease. Aust Fam Physician (2009) 0.78
The more the merrier: Faecalibacterium prausnitzii in Crohn's disease. J Gastroenterol Hepatol (2013) 0.77
Autophagy contributes to widespread neuronal degeneration in hamsters infected with the Echigo-1 strain of Creutzfeldt-Jakob disease and mice infected with the Fujisaki strain of Gerstmann-Sträussler-Scheinker (GSS) syndrome. Ultrastruct Pathol (2011) 0.77
Anesthesia for pediatric renal transplantation with and without epidural analgesia--a review of 7 years experience. Paediatr Anaesth (2005) 0.77
What is your neurologic diagnosis? Nerve sheath tumor involving the brachial plexus with involvement of the spinal cord. J Am Vet Med Assoc (2002) 0.76
Strategies for the purification of laminin-10 for studies on colon cancer metastasis. Biomed Chromatogr (2003) 0.76
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold? Gastroenterology (2012) 0.76
Effects of bacterial products on enterocyte-macrophage interactions in vitro. Biochem Biophys Res Commun (2011) 0.76
Simple clinical score. Clin Med (2011) 0.75
Identifying susceptibility to inflammatory bowel diseases: a candidate gene approach, genome-wide association studies, or both? J Gastroenterol Hepatol (2008) 0.75
Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease. J Gastroenterol Hepatol (2012) 0.75
Response to Comment on low FODMAP diet. Nutr Clin Pract (2013) 0.75
The use of cone beam imaging to determine cochlear implant electrode position in human temporal bones. Cochlear Implants Int (2013) 0.75
Barriers to continuing medical education in Australian prevocational doctors. Aust Health Rev (2008) 0.75
In this issue. J Gastroenterol Hepatol (2011) 0.75
Adalimumab levels in an infant. J Crohns Colitis (2012) 0.75
Impact of trochanteric heterotopic ossification on measurement of femoral bone density following cemented total hip replacement. J Orthop Res (2008) 0.75
Differences Across Illness Perceptions in Inflammatory Bowel Disease and Their Relationships to Psychological Distress and Quality of Life. Gastroenterol Nurs (2017) 0.75
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease. J Crohns Colitis (2015) 0.75
Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease. J Gastroenterol Hepatol (2007) 0.75
Low Incidence of Neurovascular Complications After Placement of Proximal Tibial Traction Pins. Orthopedics (2017) 0.75
High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease. Inflamm Bowel Dis (2016) 0.75
Rational investigation of upper abdominal pain. Aust Fam Physician (2008) 0.75
Education and Imaging. Hepatobiliary and pancreatic: falciform ligament necrosis. J Gastroenterol Hepatol (2012) 0.75
What may underlie recurrent purpura fulminans? Med J Aust (2007) 0.75
Journal of Gastroenterology and Hepatology. In this issue. J Gastroenterol Hepatol (2009) 0.75
Paced QT dispersion and QT morphology after radiofrequency atrioventricular junction ablation: impact of left ventricular function. Pacing Clin Electrophysiol (2003) 0.75